<--- Back to Details
First PageDocument Content
Lymph node / Axillary lymph nodes / Breast cancer treatment / Breast cancer / Swelling / Melanoma / Lymph / Sentinel lymph node / Radiation therapy / Medicine / Lymphatic system / Lymphedema
Date: 2014-02-10 08:30:17
Lymph node
Axillary lymph nodes
Breast cancer treatment
Breast cancer
Swelling
Melanoma
Lymph
Sentinel lymph node
Radiation therapy
Medicine
Lymphatic system
Lymphedema

lymphatic system with thoracic

Add to Reading List

Source URL: canceraustralia.gov.au

Download Document from Source Website

File Size: 918,60 KB

Share Document on Facebook

Similar Documents

Journal of Machine Learning ResearchSubmitted 8/15; Revised 3/16; PublishedStructure-Leveraged Methods in Breast Cancer Risk Prediction

DocID: 1vq0d - View Document

Multicausality: Confounding - Assignment solutions 1. a. Reserpine is a risk factor. Overall, the incidence of breast cancer isper 100,000 women-years in reserpine users and 6.14 per 100,000 women-years in nonuser

DocID: 1vpNA - View Document

Frequently Asked Questions: Trainees seeking a PhD education in Cancer Biology or a related area with a focus on Breast Cancer Health Disparities. 1. What is the Komen Graduate Training in Disparities Research Grant (GT

DocID: 1voV1 - View Document

_____________________________________________________________ What to Do When Someone You Know Has Been Diagnosed with Breast Cancer [Last revised Mar 2014]

DocID: 1vlqg - View Document

Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1–mediated metabolism to the product 4′ hydroxy tangeretin

DocID: 1vl9e - View Document